| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Common Stock | Options Exercise | $93,862 | +1,196 | +15% | $78.48 | 9,367 | 07 Feb 2024 | Direct | F1 |
| transaction | RGA | Common Stock | Tax liability | $95,153 | -563 | -6% | $169.01 | 8,804 | 07 Feb 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RGA | Stock Appreciation Right (right to purchase) 2014 | Options Exercise | $0 | -2,233 | -100% | $0.000000* | 0 | 07 Feb 2024 | Common Stock | 2,233 | $78.48 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents (i) 1,037 shares sold to pay the exercise price the purchase of Common Stock, and (ii) 563 shares withheld to satisfy Company tax withholding obligations, resulting in a net settlement of 633 shares. |
| F2 | SARs grants vest in 25% increments over four years, starting on December 31 of the year of grant. |